Astellas Pharma Inc
XMUN:YPH

Watchlist Manager
Astellas Pharma Inc Logo
Astellas Pharma Inc
XMUN:YPH
Watchlist
Price: 11.72 EUR -1.26%
Market Cap: €33.8B

Profitability Summary

Astellas Pharma Inc's profitability score is 48/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

48/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

48/100
Profitability
Score
48/100
Profitability
Score

Margins

Earnings Waterfall
Astellas Pharma Inc

Margins Comparison
Astellas Pharma Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
JP
Astellas Pharma Inc
TSE:4503
3.8T JPY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
269.6B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
208B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
217.7B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
93.9B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Astellas Pharma Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
JP
Astellas Pharma Inc
TSE:4503
3.8T JPY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
269.6B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
208B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
217.7B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
93.9B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Astellas Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate